Inactivation of STK11 has been shown to cause a “cold” tumor immune microenvironment by blunting the action of cytotoxic T lymphocytes and has been associated with PD‐1/PD‐L1 inhibitor resistance in NSCLC.18 The gene discussed is STK11; the disease is neoplasm.